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a b s t r a c t
We conducted a systematic review of the literature to evaluate treatment of oral leukoplakia with the
carbon dioxide (CO2) laser.
A comprehensive search of studies published between 1981 and 2015 and listed in the PubMed
(National Library of Medicine, NCBI) database yielded 378 articles which were screened in detail. Rele-
vant studies were selected according to predetermined inclusion and exclusion criteria. A total of 33
articles met the ﬁnal inclusion criteria and were analysed in detail in accordance with the PRISMA-P
statement. These full-text papers were classiﬁed as synopses (n ¼ 7), recurrence and malignant trans-
formation studies (n ¼ 17), comparative studies between CO2 laser and cold knife surgery (n ¼ 3) and
studies evaluating the efﬁcacy of CO2, Nd:YAG and KTP lasers.
According to the literature the CO2 laser is the workhorse of oral leukoplakia treatment due to its
effectiveness and low associated morbidity. However, randomized clinical trials are needed to compare
CO2 laser with other lasers. The results of our systematic review showed that there is no consensus
regarding the factors involved in higher recurrence and malignization rates, so further studies are
needed.
© 2016 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights
reserved.
1. Introduction
Oral leukoplakia (OL) is the most common potentially malignant
lesion of the oral cavity, leading, in some cases, to oral squamous
cell carcinoma (OSCC). The annual rate of malignant transformation
of OL into OSCC is approximately 1%e2% (Van der Waal, 2009).
Several treatment options have been used for OL, but, according
to the literature, cold knife surgery and carbon dioxide (CO2) laser
surgery seem to offer better outcomes than topical or systemic
medication in terms of recurrence and malignant transformation.
Although there is no evidence that treatment prevents malignant
transformation, it is recommended to treat OL with or without
dysplasia (Horch et al., 1986; Chandu et al., 2005; Brouns et al.,
2014a).
The CO2 laser was invented in 1963 by Patel (1964), but Ben-
Bassat et al. (1987) were the ﬁrst to describe its use for intraoral
treatment. Since then many studies have endorsed the advantages
and effectiveness of the CO2 laser as treatment not only for OL,
but also for other oral and maxillofacial lesions and head and
neck lesions (Chandu et al., 2005; Yang et al., 2011; Deppe et al.,
2012).
The aim of the present review article was to systematically
evaluate the effectiveness of CO2 laser treatments on OL lesions.
2. Material and methods
2.1. Search strategy
A MEDLINE (PubMed) search was conducted, with studies
published from 1981 to 2015 included in the systematic review
(SR). The SR was updated on 16th June 2015 and conducted in
accordance with the Preferred Reporting Items for Systematic
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Reviews and Meta-Analysis protocols (PRISMA-P 2015) (Moher
et al., 2015). All eligible articles were manually checked for addi-
tional references.
2.2. Search terms
A combination of the following keywords was used: oral leu-
koplakia, vaporization, CO2 laser, carbon dioxide laser, laser sur-
gery, epithelial dysplasia, malignant transformation, and
recurrence.
2.3. Article selection
To control for selection bias, two independent reviewers (AMV
and JAHM) evaluated the titles and abstracts of retrieved articles. If
it was not clear from the title and abstract whether an article met
the inclusion criteria, the full text was reviewed. Expert opinions
were excluded. When duplicate reports of the same study were
identiﬁed, only the most recent was included. Full-text articles
were then evaluated and differences between both reviewers were
solved by discussion until consensus was reached.
2.4. Inclusion criteria
The inclusion criteria for the studies were as follows: studies
reporting clinical series of patients with OL treated with the CO2
laser, studies reporting clinical series of patients with OL treated
with CO2 laser compared to other surgical techniques and, ﬁnally,
articles dealing with general aspects of OL treatment with the CO2
laser.
2.5. Exclusion criteria
The exclusion criteria were as follows: duplicated studies, ani-
mal studies, experimental laboratory studies, cohort studies with
less than 12 months follow-up, articles reporting leukoplakia in
locations other than oral, articles published in languages other than
English, French, German, Italian and Spanish and, ﬁnally, letters,
editorials and abstracts.
2.6. Data collection and analysis
The following information was collected, when possible, from
the selected studies: ﬁrst author, year, country, number of patients
treated with CO2 laser, number of different OL lesions treated in
each study, the most frequent locations for OL, recurrence rate,
malignant transformation rate, type of CO2 laser used and the
complications rate. Whenever possible, data on factors affecting
recurrence and malignant transformation were also collected.
3. Results
The initial MEDLINE search retrieved 378 articles. For multiple
publications regarding the same group of patients, only the most
recent study was included. Initial analysis of titles and abstracts
eliminated 314 articles, leaving 64 articles whose full text was
examined. A total of 33 studies met the inclusion criteria and so
were included in the ﬁnal review. Studies were classiﬁed into 4
groups (Table 1).
3.1. Synopsis articles
Seven of the articles (21.21%) were synopses. Huang et al. (2015)
retrospectively evaluated the safety and advantages of using CO2
laser in the treatment of oral mucosal lesions including vascular
malformations, OL and verrucous nevus in a group of 73 patients,
comparing their results with a control group of 20 patients treated
with the traditional scalpel. They found statistically signiﬁcant
(p < .05) better outcomes in terms of shorter operative time and
less bleeding in the patients treated with the CO2 laser. Deppe et al.
(2012) prospectively evaluated recurrence rates resulting from
different methods of CO2 laser vaporization (defocused continuous
wave, superpulsed mode plus scanner and continuous wave plus
scanner), concluding that recurrence rates were lower to a statis-
tically signiﬁcant degree for the defocused continuous wave tech-
nique followed by the continuous wave scanner and the super
pulsed plus scanner mode, in that order. Metzler (2007) reviewed
the literature on surgical management of oral mucosal dysplasia,
describing the technique, advantages and disadvantages of CO2
laser for OL treatment. Colella et al. (1995) reviewing the literature
on different methods of OL treatment, particularly focussing on CO2
laser, traditional surgery and natural or synthetic retinoids. Deymes
(1981) reported experiences with CO2 laser for OL treatment and
also for other intraoral benign neoplasms. Roodenburg and Horch
(1993) reviewed indications for CO2 laser in oral and maxillofacial
surgery, describing advantages over other methods and concluding
it to be the treatment of choice for OL. Bornstein et al. (2003)
reviewed and discussed recurrence and malignant transformation
rates for studies of OL treated with the CO2 laser from 1985 to 2000,
focussing especially on complications and wound healing.
3.2. Studies of recurrence and malignant transformation
Seventeen papers (51.51%) were classiﬁed as studies focussing
on recurrence and malignant transformation of OL in patients
treated with the CO2 laser. These studies are summarized in Table 2
(Frame, 1985; Horch et al., 1986; Chu et al., 1988; Roodenburg et al.,
1991; Chiesa et al., 1993; Huerta et al., 1999; Gooris et al., 1999;
Dunsche et al., 2000; Thomson et al., 2002; Van der Hem et al.,
2005; Chandu et al., 2005; Yang et al., 2011; Jerjes et al., 2012;
Brouns et al., 2013, 2014; Pedrosa et al., 2015; Mogedas-Vegara
et al., 2015).
All the articles were retrospective, with patients treated for
different OL locations, except for one article that focused exclu-
sively on leukoplakia of the lower lip (Gooris et al., 1999). Some
studies aimed to identify the factors (epidemiological, etiological,
clinical and histopathological) affecting recurrence and possibly
predicting malignant transformation (Table 3).
3.3. Comparative studies between CO2 laser and cold knife surgery
Three papers (9.9%) prospectively compared excision of OL by
CO2 laser versus traditional scalpel (Che et al., 2012; L!opez-Jornet
et al., 2013; Tambuwala et al., 2014). Table 4 summarizes these
studies and the parameters used to compare the two methods
(p > .05 was considered to be statistically signiﬁcant).
Table 1
Classiﬁcation of analysed oral leukoplakia articles (n ¼ 33). 1. Synopses. 2. Studies of
recurrence andmalignant transformation. 3. Comparative studies between CO2 laser
and cold knife. 4. Studies evaluating the efﬁcacy of CO2, Nd:YAG and KTP laser.
Number of
articles
Percentage
1. Synopses 7 21.21%
2. Studies of recurrence and
malignant transformation
17 51.51%
3. Comparative studies between
CO2 laser and cold knife
3 9.9%
4. Studies evaluating the efﬁcacy
of CO2, Nd:YAG and KTP laser
6 18.18%
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3.4. Studies evaluating the efﬁcacy of CO2, Nd:YAG and KTP laser
Six articles (18.18%) retrospectively evaluated OL management
with the CO2 laser, KTP laser or Nd:YAG laser. Del Corso et al. (2015)
compared the CO2 and Nd:YAG lasers OL treatment, ﬁnding no
statistical differences in terms of recurrence or malignant trans-
formation rates. However, CO2 laser excision resulted in better
outcomes than Nd:YAG laser evaporation for non-homogeneous OL
(p ¼ .04) and OL with mild dysplasia (p ¼ .03). Lim et al. (2010)
compared CO2 and KTP laser treatment in cohorts of 45 and 30
patients, respectively, ﬁnding a statistically signiﬁcant reduction in
terms or recurrence (p ¼ .049) for patients treated with the KTP
laser, hypothesizing that the KTP laser may bemore effective owing
to deeper tissue penetration and thermal scatter. Ishii et al. (2004)
evaluated treatment with CO2, Nd:YAG and KTP lasers of 116 pa-
tients presenting with 154 OLs, observing a recurrence rate of 29.3%
Table 2
Studies of recurrence and malignant transformation. ni: not indicated; sp: super pulsed; cw: continuous wave.
Author, year, country Patients Lesions Location Recurrence
rate
Malignant
transformation
rate
Laser/Wattage Complications Follow-up
Mogedas 2015,
Spain
65 65 Tongue 32.3% 33.8% 15.4% Lumenis sp/15 W 7.7%
Pain
15 months
Pedrosa 2015,
Portugal
59 59 ni 40.7% 10.2% ni cw/6e15 W 0% 43.75 months
Brouns et al., 2014,
2013, Netherlands
35 35 Tongue 25.7% 40% 14% Visor 400 sp cw/4e8 W 2.85%
Mental nerve
paraesthesia
61.5 months
Jerjes 2012, UK 77 123 Tongue 37.4% 19.5% 10.4% Sharplan sp cw/2e15 W 0% 6.4 years
Yang 2011, Taiwan 114 114 Cheek 53.5% 17.5% 11.4% Lumenis cw/12e15 W 0% 3.4 years
Van der Hem, 2005
Netherlands
200 282 Tongue 22.7% 9.9% 1.1% Sharplan 791, Cavitron,
Sharplan 40C/15e20 W
ni 52 months
Chandu 2005,
Australia
43 73 ni 28.9% 7.3% Sharplan 743/10e15 W 6.9%
Temporary mental
nerve paraesthesia,
headache, pain
47.2 months
Thomson 2002, UK 57 62 Floor of
mouth 42%
24% 7% Ultrapulse 1000/10e15 W 7% (4/57)
Sialadenitis,
lingual
nerve paraesthesia
18 months
Dunsche 2000,
Germany
91 168 Floor of
mouth 41.7%
4.9% 1.5% ni/3e5 W ni 35.2 months
Gooris 1999, Netherlands 23 27 Lips 100% 14.8% 0% Sharplan 791, Cavitron 33A,
Sharplan 1025
(defocused)/8e10 W
ni 3e192months
Huerta 1999,
Spain
34 34 Tongue 26.5%/
Buccal
mucosa 26.5%
25.8% X 10 W ni 12 months
Chiesa 1993,
Italy
167 167 Buccal
mucosa 59.2%
34.73% 3% Continuous wave/9e12 W ni 52 months
Roodenburg 1991,
Netherland
70 103 Buccal
mucosa 28%
9.7% 0% Sharplan 791, Cavitron
300A defocused/15e20 W
ni 5.3 years
Chu 1988, USA 29 38 Floor of mouth,
ventral tongue
36.8%
10.8% 2.6% Coherent 450/451
XLG/3,5e20 W
13.8%
Granuloma,
bleeding,
5 years
Horch 1986,
Germany
32 50 Cheek 64% 22% ni Defocused/15e20 W ni 37 months
Frame 1985, UK 63 75 ni 3.1% 0% Coherent 450, Sharplan
733/10 W
ni 29 months
Table 3
Factors related to recurrence and malignant transformation.
Author, year Factors affecting recurrence Factors predicting malignant transformation
Mogedas-Vegara, 2015 Gingiva vs. tongue (p ¼ .032) X
Pedrosa et al., 2015 Moderate to high-grade dysplasia (p ¼ .006) X
Brouns, 2013b Not reported Size 4 cm or more (p ¼ .034)
Jerjes, 2012 Erythroleukoplakia (p < .001)
Non-homogeneous OL (p < .001)
Heavy life-long smokers ± heavy
life-long alcohol consumers (p < .001)
Erythroleukoplakia (p < .001)
Non-homogeneous leukoplakia (p < .001)
Heavy life-long smokers ± heavy life-long
alcohol consumers (p < .001)
Yang, 2011 Smoking continuation after
laser treatment (p ¼ .008)
Multiple-focus OL (p ¼ .006)
Non-homogeneous OL (p ¼ .04)
High-grade displasia (p ¼ .012)
Not reported
Chandu, 2005 Alcohol consumption (p ¼ .034)
Previous malignancy (p ¼ .018)
Not reported
Thomson, 2002 X X
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and a malignization rate of 1.2%. Excision with the CO2 or KTP laser
was preferred for non-contact application for non-keratinized
epithelium OL. Non-contact CO2 laser and contact Nd:YAG laser
vaporization approaches were used for OL located on the gingiva or
hard palate. Schoelch et al. (1999) reported OL management of 55
patients based on combining CO2 and Nd:YAG lasers. In follow-up
for more than 6 months (range 6e176 months), 29 patients ob-
tained complete control of their lesions, 19 patients obtained con-
trol after small recurrences treatedwith subsequent laser surgery, 2
patients had full recurrence and 5 patients developed squamous
cell carcinoma.White et al. (1998), for 39 patients with OL, reported
recurrence rates of 27% and 24% in patients treated with the
Nd:YAG laser and the CO2 laser, respectively. Gendelman et al.
(1993) found no signiﬁcant differences in a sample of 8 patients
with OLs treated with the Nd:YAG and CO2 lasers.
4. Discussion
Oral leukoplakia is considered to be the most potentially ma-
lignant lesion of the oral cavity and is associated with the devel-
opment of OSCC with an annual malignant transformation rate of
1% (Van derWaal, 2009). Therefore, early recognition, management
and follow-up should be performed in order to improve long-term
survival rates and minimize treatment. Clinical suspicion of oral
leukoplakia, should eliminate possible etiological factors (smoking,
Candida, dental restorations or mechanical friction) and a subse-
quent evaluation in 2 weeks is needed. If after this time the injury
persists a biopsy is recommended. Incisional biopsy and histo-
pathological examination are the gold standard in the diagnosis of
OL although, there may be discrepancies between the results for
incisional biopsy compared to excisional biopsy, producing a po-
tential underdiagnosis of dysplastic lesions by 28% and masking an
OSCC diagnosis in 9% of the cases (Mogedas-Vegara et al., 2015;
Brouns et al., 2014; Goodson et al., 2012; Van der Waal, 2009).
Regarding follow-up examinations in patients with OL, there are
authors that recommend a tight follow-up every 3 months in the
ﬁrst year, every 6 months in the second year and annually for life
thereafter, but there is currently no evidence about the possible
value of follow-up (Mogedas et al., 2015; Kumar et al., 2013; Van
der Waal, 2009). To our knowledge this is the ﬁrst systematic re-
view of OL treatment with the CO2 laser.
CO2 laser has been used for OL excision or evaporation for more
than 30 years. Given that it is a very precise tool associated with
minimal complications and good disease control, it has become a
common procedure for OL treatment worldwide.
One of the most important issues relating to CO2 laser treatment
is recurrence and malignization rates, reported in the literature as
ranging between 3 and 1% and 40.7% and between 0% and 15.4%,
respectively, for follow-up from 1 to 6.4 years. Some authors have
used the term cumulative disease-free survival (DFS) in order to
avoid confusion in reporting recurrence rates per lesion or per
patient. Chiesa et al. (1993) reported DFS rates of 70.7% and 51.5% at
3 and 5 years, respectively; Chandu and Smith (2005) reported DFS
rates of 55.4% (95% CI; 38.3e72.5) after 3 years and of 33.9% (95% CI;
10.2e57.5) after 5 years; Pedrosa et al. (2015) reported an overall
DFS rate of 88% after 1-year follow-up. Since it seems that recur-
rence is unavoidable due to ﬁeld cancerization, tight follow-up is
advisable (Slaughter et al., 1953; Yang et al., 2011; Mogedas-Vegara
et al., 2015). The treatment of other oral lesions such as erosive
lichen planus with CO2 laser, appears to inﬂuence the recurrence
rate, as well as the malignant transformation to oral OSCC, but
further randomised prospective clinical trials are needed (Mücke
et al., 2015).
Although several studies have shown that certain factors
(high-grade dysplasia, erythroleukoplakia, smoking, alcohol,
non-homogeneous or multiple-focus OL, 4-cm or larger lesions,
previous malignancies) may be related to higher recurrence and
malignant transformation rates, consensus is still lacking so further
studies are needed. On the other hand, although there is no
evidence that treatment prevents OL developing into OSCC, the
transformation rate can be signiﬁcantly decreased with CO2 laser
treatment (Yang et al., 2011; Jerjes et al., 2012; Brouns et al., 2013,
2014; Pedrosa et al., 2015; Mogedas-Vegara et al., 2015).
The most frequent OL sites in the reviewed articles were the
tongue (4 articles) and the cheek (4 articles). Huerta et al. (1999)
reported the same percentage of lesions (26.5%) on the tongue
and on the cheek. Only one article focused on patients with lesions
located only on the lips (Gooris et al., 1999).
The CO2 laser is a versatile instrument and not only allows
vaporization and excision, but also reparation of diseased tissue
with also obtaining a satisfactory effect and low complication rate
(Huang et al., 2015). In implementing OL treatment with the CO2
laser, there is no standardized protocol of how to carry out the
procedure. While some authors excised the lesion (Del Corso et al.,
2015), there are others that vaporized the lesion (Huerta et al.,
1999; Gooris et al., 1999; Dunsche et al., 2000; Van der Hem
et al., 2005; Chandu et al., 2005; Deppe et al., 2012; Brouns et al.,
2013; Pedrosa et al., 2015; Mogedas-Vegara et al., 2015) and yet
others combined both approaches (Thomson et al., 2002; Yang
et al., 2011). The need for an accurate pre-operative biopsy spec-
imenwhich is as representative as possible of the lesion as a whole,
to ensure ablation of a carcinoma is not occurring, is mandatory.
This is especially important if only vaporization of the OL is per-
formed due to the impossibility of examining the whole lesion
histologically (Goodson et al., 2012; Chandu, 2005). Del Corso et al.,
were the ﬁrst group that compared the excision and the vapor-
ization of OL, but this study was madewith different lasers (the CO2
and the Nd:YAG respectively) (Del Corso et al., 2015). It seems that
Table 4
Comparative studies between CO2 laser and cold knife surgery.
Author, year Study Laser (n)/scalpel
(n) (patients)
Outcomes for laser vs
cold knife (p < .05)
Outcomes for laser vs cold knife (p > .05)
Tambuwala,
2014
Non-
randomized
25/25 Less bleeding
Less oedema
Scarring distribution
after 1 month (p ¼ .045)
Postoperative pain (p ¼ .208, 1st post-op day,
and p ¼ .533, 2nd post-op day)
Chee and Sasaki,
2013
Randomized 24/23 Less bipolar cautery per
square cm
Less blood loss
Less margin needed to clear
specimens by frozen section (p ¼ .03)
Excision time
L!opez-Jornet,
2013
Randomized 20/28 Less pain (p ¼ .021) and swelling
(p ¼ .019) 12e48 h after surgery
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small lesions may be successfully treated either by excision or
vaporization, whereas larger, multiple and not well circumscribed
lesions may be better treated with vaporization in order to avoid
retractions and functional problems in large lesions and minimize
postoperative pain. Multifocal cases of OL seems that are at more
risk of recurrence due to the “ﬁeld of cancerization” and multiple
biopsies (“ﬁeld mapping”) should be considered, but there is no
special protocol for treating this situation. There is a low level of
evidence regarding this topic and further studies comparing the
two techniques, with the CO2 laser, in terms of effectiveness and
whether they affect recurrence and malignancy rates, should be
conducted (Del Corso et al., 2015; Mogedas et al., 2015; Yang et al.,
2011; Chandu et al., 2005).
Although different CO2 laser methods have been used, the
classical defocused continuous wave technique seems to be the
most effective in terms of minimizing the risk of recurrence,
probably because it penetrates deeper and destroys more
dysplastic cells (Deppe et al., 2012).
The complications rated only reported in 8 studies and mostly
pain-related d ranged from 0% to 13.8%. Apart from pain, other
complications reported were mental nerve paraesthesia, lingual
nerve paraesthesia, headache, sialadenitis, granuloma formation
and bleeding (Chu et al., 1988; Thomson et al., 2002; Chandu et al.,
2005; Yang et al., 2011; Jerjes et al., 2012; Brouns et al., 2013;
Pedrosa et al., 2015; Mogedas-Vegara et al., 2015).
For postoperative care most studies recommended a 0.12%
chlorhexidine mouthwash and non-steroidal anti-inﬂammatory
drugs or paracetamol (Roodenburg et al., 1991; Huerta et al., 1999;
Van der Hem et al., 2005; Jerjes et al., 2012; Brouns et al., 2013;
Mogedas-Vegara et al., 2015).
Only 3 articles compared the CO2 laser and cold knife surgery for
OL treatment, but it seems advisable to recommend the former as it
is associated with less postoperative pain, swelling and scarring
and also leads to better intraoperative haemostasis control. The
margins needed to clear a specimen is also better for the CO2 laser.
The reviewed literature contained no randomized trials that
compared traditional scalpel and CO2 laser in terms of recurrence
and malignant transformation.
Although other laser systems (Nd:YAG and KTP) have also been
proposed for OL treatment, few studies have directly compared
their efﬁcacy. Since there is still no consensus on their superiority,
the CO2 laser continues to be the workhorse for OL treatment.
5. Conclusions
Treatment of OL with the CO2 laser is a reliable, reproducible
technique associated with low complications and morbidity rates
and suitable for routine practice. Because of the high recurrence
and malignant transformation rates, tight follow-up and patient
education to eliminate risk factors are recommended. Randomized
controlled trials are needed to establish indications and effective-
ness of the different surgical methods for treating OL, especially in
terms of recurrence and malignant transformation.
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